Press Releases

Thermo Fisher Support of COVID-19 Response Continues to Expand with U.S. Government Contract for Products Used in Sample Collection

Thermo Fisher Scientific Inc., the world leader in serving science, announced it has received a contract from the U.S. government to provide highly specialized viral transport media (VTM) for COVID-19 sample collection. The VTM is used during collection of...

FDA approves Roche’s Tecentriq as a first-line monotherapy for certain people with metastatic non-small cell lung cancer

Roche announced that the US FDA has approved Tecentriq as a first-line (initial) treatment for adults with metastatic non-small cell lung cancer (NSCLC) whose tumours have high PD-L1 expression (PD-L1 stained ≥ 50% of tumour cells or PD-L1...

Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test

Duke-NUS Medical School (Duke-NUS), a research intensive graduate-entry medical school, GenScript Biotech Corporation, a leading global biotechnology company, and the Diagnostics Development Hub (DxD) at Singapore's Agency for Science, Technology and Research (A*STAR), announced an exclusive agreement to co-develop...

WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform

WuXi Advanced Therapies, a leading global Contract Development and Manufacturing Organization (CDMO) offering end-to-end contract services for the advanced therapies industry, announced the expansion of its service capabilities to offer a fully integrated Closed Process CAR-T Cell Therapy Platform....

Sharp Acquires US Pharmaceutical Packaging Facility

Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has acquired a pharmaceutical packaging facility from Quality Packaging Specialists International, LLC (QPSI). The site, located in Macungie, Pennsylvania, will offer primary and secondary...

Nori Health offers free access to smart chatbot for people with Crohn’s and Colitis during the crisis

Covid-19 forced the most vulnerable in our society to go into self-isolation, such as the 600.000 people living in the UK with Inflammatory Bowel Disease (IBD) of which Crohn’s and Colitis are most common. To help manage their disease more...

Leinco Technologies and Vanderbilt University Medical Center partner to deliver rapid, point of care COVID-19 diagnostic test

Leinco Technologies, Inc., a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, conjugates and provider of custom manufacturing services to the diagnostic and biopharmaceutical industries, today announced an agreement with Vanderbilt University Medical Center (VUMC) to scale up...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read